Thromboxane–prostaglandin receptor antagonist, terutroban, prevents neurovascular events after subarachnoid haemorrhage: a nanoSPECT study in rats
David Lagier(Inserm), Lionel Velly(Centre National de la Recherche Scientifique), Jean‐Charles Martin(Apple (Israel)), Philippe Garrigue(Aix-Marseille Université), Laura Giacomino(Centre National de la Recherche Scientifique), David Tonon(Assistance Publique Hôpitaux de Marseille), Nicolas Bruder(Aix-Marseille Université), Benjamin Guillet(Inserm), Marie‐Christine Alessi(Hôpital de la Timone)
Cited by 13
Related Papers
Critical Care Management of Patients Following Aneurysmal Subarachnoid Hemorrhage: Recommendations from the Neurocritical Care Society’s Multidisciplinary Consensus Conference
|Neurocritical Care|2011|1.1k
Sodium bicarbonate therapy for patients with severe metabolic acidaemia in the intensive care unit (BICAR-ICU): a multicentre, open-label, randomised controlled, phase 3 trial
|The Lancet|2018|395
Exome sequencing identifies NBEAL2 as the causative gene for gray platelet syndrome
|Nature Genetics|2011|279
Reliability of standard pupillometry practice in neurocritical care: an observational, double-blinded study
|Critical Care|2016|260
Management of severe traumatic brain injury (first 24 hours)
|Anaesthesia Critical Care & Pain Medicine|2017|238